C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients

BACKGROUND: Serum C-reactive protein (CRP) is a biomarker of an acute inflammatory response and has been successfully used as a prognostic predictor for several malignancies. However, the clinicopathological significance of CRP levels in hepatocellular carcinoma (HCC) patients being treated with PD-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yiyang, Lu, Lianghe, He, Zhangping, Xu, Zhishen, Xiang, Zhicheng, Nie, Run-Cong, Lin, Wenping, Chen, Wenxu, Zhou, Jie, Yin, Yixin, Xie, Juanjuan, Zhang, Youcheng, Zheng, Xueyi, Zhu, Tianchen, Cai, Xiaoxia, Li, Peng, Chao, Xue, Cai, Mu-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854259/
https://www.ncbi.nlm.nih.gov/pubmed/35185894
http://dx.doi.org/10.3389/fimmu.2022.808101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854259/
https://www.ncbi.nlm.nih.gov/pubmed/35185894
http://dx.doi.org/10.3389/fimmu.2022.808101

Ejemplares similares